AEON Biopharma (AEON)

AEON Biopharma on one page: short interest, daily short volume, fails to deliver, large holders, earnings dates and insider trades. Listed on NYSE.

Download CSV

3.3M

Short interest

settlement 2026-10-15

1.5

Days to cover

+0.5 days vs prior

51.5%

Short share of volume

2026-11-02

64,473

Fails to deliver

settlement 2026-10-14

Fri 13 Nov

Next earnings

estimated date

$243K

Insider flow, 90 days

1 buys, 0 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in AEON is 3,250,700 shares, up 302,749 shares over the last month. Over the last 48 readings it ranged from 37,337 shares (31 October 2025) to 3,250,700 shares (15 October 2026). The latest reading sits at the top of that range. At the reported average volume of 2.1M shares a day that is 1.5 days to cover.

Embed this chart.The embed keeps its attribution line.

<iframe src="https://xoomar.com/embed/stocks/aeon" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

Preview Dark previewAdd ?theme=dark to the src for a dark chart.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-10-15	3,250,700	+49.7%	2,133,944	1.52
2026-09-30	2,171,628	-26.3%	11,385,809	1.00
2026-09-15	2,947,951	+62.8%	24,523,114	1.00
2026-08-31	1,811,171	+60.8%	7,389,741	1.00
2026-08-14	1,126,698	+28.5%	343,615	3.28
2026-07-31	876,967	-21.2%	993,401	1.00
2026-07-15	1,112,789	+594.3%	6,550,697	1.00
2026-06-30	160,269	-9.9%	28,986	5.53
2026-06-15	177,895	-18.9%	32,980	5.39
2026-05-29	219,220	-5.5%	72,592	3.02
2026-05-15	231,888	+48.3%	69,649	3.33
2026-04-30	156,396	+51.5%	95,585	1.64
2026-04-15	103,230	-28.7%	183,059	1.00
2026-03-31	144,810	-48.0%	84,814	1.71
2026-03-13	278,199	+32.7%	64,976	4.28
2026-02-27	209,615	-5.6%	106,173	1.97
2026-02-13	221,971	-12.5%	90,717	2.45
2026-01-30	253,766	+40.6%	353,631	1.00
2026-01-15	180,486	+308.1%	202,907	1.00
2025-12-31	44,230	-29.6%	230,847	1.00
2025-12-15	62,848	+12.0%	141,854	1.00
2025-11-28	56,119	-46.1%	293,040	1.00
2025-11-14	104,198	+179.1%	240,488	1.00
2025-10-31	37,337	-83.5%	334,092	1.00
2025-10-15	226,424	+98.2%	409,345	1.00
2025-09-30	114,239	+9.1%	115,255	1.00
2025-09-15	104,751	-32.8%	86,440	1.21
2025-08-29	155,882	-38.6%	70,133	2.22
2025-08-15	253,955	-22.6%	104,388	2.43
2025-07-31	328,300	-9.1%	119,576	2.75
2025-07-15	361,308	-28.0%	165,562	2.18
2025-06-30	502,026	+15.9%	263,780	1.90
2025-06-13	433,279	-63.2%	607,681	1.00
2025-05-30	1,178,195	+567.1%	3,397,945	1.00
2025-05-15	176,612	+156.2%	313,379	1.00
2025-04-30	68,941	-81.4%	265,409	1.00
2025-04-15	371,082	+76.6%	549,699	1.00
2025-03-31	210,177	+20.8%	672,906	1.00
2025-03-14	173,994	-55.8%	16,350,297	1.00
2025-02-28	393,233	-85.3%	1,630,144	1.00
2025-02-14	2,665,565	-10.5%	4,291,327	1.00
2025-01-31	2,977,404	+149.7%	69,557,525	1.00
2025-01-15	1,192,441	+1851.9%	24,174,742	1.00
2024-12-31	61,092	-68.4%	179,731	1.00
2024-12-13	193,534	+131.9%	461,241	1.00
2024-11-29	83,437	-49.2%	119,200	1.00
2024-11-15	164,257	+19.5%	131,384	1.25
2024-10-31	137,444	-10.2%	79,637	1.73

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of AEON volume is 51.5%, up 29.5 points over the last five sessions. Over the last 30 readings it ranged from 18.0% (22 October 2026) to 68.3% (13 October 2026). The latest reading is 7.9 points above the 30-session average of 43.6%, on 214K shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-11-02	110K	214K	51.5%	0
2026-10-30	90K	479K	18.8%	0
2026-10-29	479K	773K	62.0%	0
2026-10-28	112K	248K	45.0%	100
2026-10-27	19K	83K	23.3%	0
2026-10-26	11K	51K	22.0%	0
2026-10-23	70K	127K	55.3%	0
2026-10-22	12K	64K	18.0%	0
2026-10-21	21K	90K	23.9%	0
2026-10-20	59K	159K	37.1%	0
2026-10-19	120K	333K	36.2%	0
2026-10-16	67K	127K	53.0%	2
2026-10-15	100K	207K	48.6%	0
2026-10-14	202K	430K	46.9%	29,103
2026-10-13	576K	844K	68.3%	63,659
2026-10-12	351K	679K	51.7%	6,663
2026-10-09	483K	995K	48.5%	32,295
2026-10-08	238K	627K	38.0%	0
2026-10-07	964K	2.0M	48.3%	7,110
2026-10-06	686K	1.6M	43.9%	12,011
2026-10-05	374K	1.0M	35.7%	10,907
2026-10-02	1.1M	2.1M	50.3%	44,101
2026-10-01	1.6M	3.6M	43.7%	15,157
2026-09-30	39.7M	70.4M	56.4%	269,404
2026-09-29	63K	141K	45.0%	0
2026-09-28	111K	205K	54.5%	18,854
2026-09-25	184K	351K	52.5%	0
2026-09-24	160K	327K	48.8%	0
2026-09-23	322K	614K	52.4%	250
2026-09-22	47K	174K	27.1%	1

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 14 October 2026, the fails-to-deliver balance in AEON is 64,473 shares, up 59,466 shares over the last settlement date. Over the last 30 readings it ranged from 35 shares (24 September 2026) to 435,695 shares (11 September 2026).

Settlement	Shares failed	Price	Value
2026-10-14	64,473	$0.23	$15K
2026-10-13	5,007	$0.25	$1K
2026-10-09	5,068	$0.31	$2K
2026-10-08	261	$0.31	$81
2026-10-07	114,075	$0.29	$33K
2026-10-06	1,493	$0.27	$403
2026-10-05	63,759	$0.28	$18K
2026-10-02	20,548	$0.29	$6K
2026-10-01	204,178	$0.30	$61K
2026-09-28	35	$0.26	$9
2026-09-25	48,344	$0.26	$13K
2026-09-24	35	$0.26	$9
2026-09-23	10,820	$0.26	$3K
2026-09-22	20,720	$0.25	$5K
2026-09-21	25,665	$0.24	$6K
2026-09-17	83	$0.26	$22
2026-09-16	49,203	$0.27	$13K
2026-09-15	48,932	$0.29	$14K
2026-09-14	17,698	$0.33	$6K
2026-09-11	435,695	$0.29	$126K
2026-09-10	41,928	$0.23	$10K
2026-09-09	11,410	$0.24	$3K
2026-09-08	50,057	$0.24	$12K
2026-09-04	33,621	$0.25	$8K
2026-09-03	4,213	$0.27	$1K
2026-09-02	2,802	$0.28	$785
2026-09-01	20,573	$0.30	$6K
2026-08-31	4,920	$0.31	$2K
2026-08-28	293,554	$0.29	$85K
2026-08-27	327,299	$0.25	$82K

Insider trades

SEC Form 4, newest first. JSON

Insiders at AEON reported 1 open-market buy worth $243K in the last 90 days and no open-market sells. Latest filing: LYNCH TIMOTHY P (10% owner) on 2026-08-19.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2026-08-19	LYNCH TIMOTHY P	10% owner	Buy	1.1M	$0.21	$243K	6.5M
2026-06-17	Thunen Shelley B	Director	Grant	223K	$0.00	$0	259K
2026-06-17	PALMISANO ROBERT J	Director	Grant	223K	$0.00	$0	259K
2026-06-17	Forth Marc	Director	Grant	223K	$0.00	$0	973K
2026-06-17	FISCHER JOST	Director	Grant	223K	$0.00	$0	489K
2026-06-17	Carter Eric G	Director	Grant	223K	$0.00	$0	259K
2026-04-02	Bencich John	CHIEF FINANCIAL OFFICER	Grant	755K	$0.00	$0	755K
2026-03-04	Wilson Alexander Blair	CLO, CSO, and Corp Secretary	Grant	1.3M	$0.00	$0	2.2M
2026-03-04	Sy Jennifer	PRINCIPAL ACCOUNTING OFFICER	Grant	926K	$0.00	$0	1.5M
2026-03-04	Oh Chad	CHIEF MEDICAL OFFICER	Grant	1.3M	$0.00	$0	2.2M
2026-02-17	Bancroft Robert E.	PRESIDENT & CEO	Grant	3.0M	$0.00	$0	3.2M
2026-02-17	Wilson Alexander Blair	CLO, CSO, and Corp Secretary	Grant	863K	$0.00	$0	866K
2026-02-17	Sy Jennifer	PRINCIPAL ACCOUNTING OFFICER	Grant	575K	$0.00	$0	575K
2026-02-17	Oh Chad	CHIEF MEDICAL OFFICER	Grant	863K	$0.00	$0	867K
2025-05-21	FISCHER JOST	Director	Buy	60K	$0.49	$29K	267K
2025-05-20	FISCHER JOST	Director	Buy	60K	$0.51	$31K	207K
2025-05-19	FISCHER JOST	Director	Buy	50K	$0.50	$25K	147K
2025-05-14	Bancroft Robert E.	President & CEO	Grant	177K	$0.00	$0	177K
2024-08-31	Thunen Shelley B	Director	Grant	36K	$0.00	$0	36K
2024-08-31	Carter Eric G	Director	Grant	36K	$0.00	$0	36K
2024-08-31	Sy Jennifer	PRINCIPAL ACCOUNTING OFFICER	Grant	18K	$0.00	$0	18K
2024-08-31	Oh Chad	CHIEF MEDICAL OFFICER	Grant	192K	$0.00	$0	293K
2024-08-31	FISCHER JOST	Director	Grant	36K	$0.00	$0	97K
2024-08-31	Wilson Alexander Blair	EXEC VP, CLO & CORP SECRETARY	Grant	180K	$0.00	$0	262K
2024-08-31	Forth Marc	CHIEF EXECTUIVE OFFICER	Grant	471K	$0.00	$0	751K
2024-08-31	PALMISANO ROBERT J	Director	Grant	36K	$0.00	$0	36K
2023-08-11	Strathspey Crown Holdings Group, LLC	TenPercentOwner	Sell	7.4M	$10.00	$73.8M	2.0M
2023-07-21	FISCHER JOST	Director	Grant	2K	price not stated in the filing	not stated	2K
2023-07-21	FISCHER JOST	Director	Grant	13K	price not stated in the filing	not stated	13K
2023-07-21	Grodnensky Oleg	TenPercentOwner	Conversion	89K	price not stated in the filing	not stated	7.0M
2023-07-21	Grodnensky Oleg	TenPercentOwner	Conversion	6.9M	price not stated in the filing	not stated	6.9M

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

7 holders report 5% or more of AEON in their latest filing, 2 on Schedule 13D (active intent). The largest reported stake is Daewoong Co.,Ltd. ("DWC") at 50.0% of the class (12,009,737 shares), filed 2026-01-29 for an event on 2026-01-21.

Filed	Form	Holder	Shares	Of class	Event
2026-08-21	13G	Timothy P. Lynchindividual	6.5M	13.0%	2026-08-19
2026-07-21	13G	Stonepine Capital Management, LLCinvestment adviser, other entity	6.9M	9.9%	2026-07-15
2026-07-21	13G	Stonepine Capital, L.P.partnership	6.9M	9.9%	2026-07-15
2026-07-21	13G	Stonepine GP, LLCother entity	6.9M	9.9%	2026-07-15
2026-07-21	13G	Jon M. Plexicoparent holding company, individual	6.9M	9.9%	2026-07-15
2026-01-29	13D	Daewoong Co.,Ltd. ("DWC")corporation	12.0M	50.0%	2026-01-21
2026-01-29	13D	Daewoong Pharmaceutical Co. Ltd ("DWP")corporation	12.0M	49.8%	2026-01-21
2025-10-14	13G/Ano. 2	Alta Partners LLCother entity	250K	2.1%	2025-09-30

What this page is

AEON Biopharma in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows AEON Biopharma (AEON), SEC CIK 1837607, listed on NYSE. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest: FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
Large holders: SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-21.JSON and CSV
Earnings dates: SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-12.JSON and CSV
Insider trades: SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-08-19.JSON and CSV
Company record: EDGAR filing index for CIK 1837607Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 10 requests a minute without a key, 30 with a free key from a free account.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of AEON is sold short?

3,250,700 shares were held short at the 2026-10-15 settlement, 1.5 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is AEON's daily short volume?

On 2026-11-02, 110,382 of the 214,458 AEON shares reported to FINRA were sold short, 51.5% of the day's reported volume. Short volume is a flow for one day, not a position.

Does AEON have fails to deliver?

The SEC's latest file shows 64,473 AEON shares failed to deliver at settlement 2026-10-14. Fails are reported per settlement date and published twice a month with a lag.

Are AEON insiders buying or selling?

Insiders at AEON reported 1 open-market buy worth $243K in the last 90 days and no open-market sells. Latest filing: LYNCH TIMOTHY P (10% owner) on 2026-08-19.

Who owns 5% or more of AEON?

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.

AEON Biopharma (AEON)

Short interest

Daily short volume

Fails to deliver

Insider trades

Large holders (13D and 13G)

AEON Biopharma in the regulatory record

Source and updates

How to read it

Other company pages

Datasets

Frequently Asked Questions